戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 technical factors, causing the inaccuracy of 3D echocardiography.
2  patients), we validated these CT metrics to 3D echocardiography.
3 atients with functional TR who had real-time 3D echocardiography.
4 eep by 3D echocardiography, and 2 baboons by 3D echocardiography.
5    MV size measured by CT is comparable with 3D echocardiography.
6  dysfunction evaluated by three-dimensional (3D) echocardiography.
7 rticipants also underwent three-dimensional (3D) echocardiography.
8 nd EF using transthoracic three-dimensional (3D) echocardiography; (2) investigate the influence of a
9 acquisition for the annulus from 3 humans by 3D echocardiography, 3 sheep by sonomicrometry array loc
10 To demonstrate this method, paired real-time 3D echocardiography (3DE) and cardiac magnetic resonance
11 nths after inferior myocardial infarction by 3D echocardiography; 6 were untreated and 6 were treated
12        Recent advances in three-dimensional (3D) echocardiography allow us to address uniquely 3D sci
13                    Agreement was better with 3D echocardiography and cardiac MRI (mean bias, -1.6% +/
14  patients and matched healthy subjects using 3D echocardiography and demonstrates that alteration on
15  (CT)-based measurements of MV leaflets with 3D echocardiography and determine the relationship of th
16  low variability, and low bias between rapid 3D echocardiography and electron-beam computed tomograph
17                Pre- and poststress real-time 3D echocardiography and SPECT images were acquired in 20
18 on information from real-time 3-dimensional (3D) echocardiography and SPECT, respectively.
19 ic heart failure exacerbated, as measured by 3D-echocardiography and invasive hemodynamics.
20 onomicrometry array localization, 2 sheep by 3D echocardiography, and 2 baboons by 3D echocardiograph
21 n 74 participants who underwent cardiac MRI, 3D echocardiography, and 2D echocardiography, the mean L
22 ges and equations could help standardize the 3D echocardiography assessment of RV volumes and functio
23 se, were studied at the same visit with both 3D echocardiography (echo) and magnetic resonance imagin
24                    Mechanistic insights from 3D echocardiography (echo) can guide therapy.
25                        The rapid-acquisition 3D echocardiography extends the use of a multiplane, int
26        Accuracy of newly developed real-time 3D echocardiography for determining RV volume and functi
27 rmine the feasibility of using fast nongated 3D echocardiography for fetal volumetric and mass assess
28  for detection of EF less than 50%, although 3D echocardiography had 53% and 47%, respectively.
29                                              3D echocardiography has become the echocardiographic mod
30 rogressive development of three-dimensional (3D) echocardiography has made it possible to evaluate th
31 with closure area measured by 3-dimensional (3D) echocardiography have been related to FMR.
32 ume), stroke volume, and EF were measured by 3D echocardiography in 540 healthy adult volunteers, pro
33          TVA shape was examined by real-time 3D echocardiography in 75 patients: 35 with functional T
34                       Using 2D and real-time 3D echocardiography in an ovine model of chronic IMR, we
35                                 Quantitative 3D echocardiography in patients with PH demonstrated mor
36 ceptance until the introduction of real-time 3D echocardiography in the first decade of the 21st cent
37                                              3D echocardiography is becoming indispensable in guiding
38 hat RV longitudinal deformation derived from 3D echocardiography is predictive of adverse outcomes an
39 n of conventional 2D and Doppler methods and 3D echocardiography is recommended in the evaluation of
40 on measured with standard and 3-dimensional (3D) echocardiography, left ventricular ejection fraction
41 technology and increases in computing power, 3D echocardiography now provides unprecedented images of
42                     Real-time 3-dimensional (3D) echocardiography now allows dynamic volumetric imagi
43 he latest developments in three-dimensional (3D) echocardiography of mitral valve prolapse.
44                               Cardiac CT and 3D echocardiography produced similar results for total l
45               Cardiac CT (CCT) and real-time 3D echocardiography (RT3DE) are being used increasingly
46         We developed and validated real-time 3D echocardiography (RT3DE) as a novel method to assess
47  cardiomyopathy (DCM-MR) by use of real-time 3D echocardiography (RT3DE).
48                                    Real-time 3D echocardiography showed a complicated 3D structure of
49                                    Real-time 3D echocardiography, SPECT, advance processing, and imag
50 he clinical feasibility of rapid-acquisition 3D echocardiography to estimate left ventricular end-dia
51  search strategy based on primary key words: 3D echocardiography, transesophageal echocardiography, c
52                    RECENT FINDINGS: Although 3D echocardiography was invented in 1974, it did not gai
53 effect with actual valve shapes in patients, 3D echocardiography was used to reconstruct a typical sp
54                           Three-dimensional (3D) echocardiography was obtained before and immediately
55                                           By 3D echocardiography, we measured the tethering distance
56 ral, and lateral) were assessed by real-time 3D echocardiography with 3D software.